2023
DOI: 10.1016/j.jbc.2023.103026
|View full text |Cite
|
Sign up to set email alerts
|

Hepatocyte estrogen sulfotransferase inhibition protects female mice from concanavalin A–induced T cell–mediated hepatitis independent of estrogens

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 24 publications
0
1
0
Order By: Relevance
“…The administration of ConA activates abnormal hepatocyte immunity mainly through stimulating immune cells such as neutrophils, T cells and NK cells. Also, inflammation and immune stimulation are maintained by various endogenous inflammatory mediators such as interferon-gamma (IFNγ), tumor necrosis factor-alpha (TNF-α) and interleukins (IL-1β, IL-6, IL-10 and IL-17) [6,7].…”
Section: Introductionmentioning
confidence: 99%
“…The administration of ConA activates abnormal hepatocyte immunity mainly through stimulating immune cells such as neutrophils, T cells and NK cells. Also, inflammation and immune stimulation are maintained by various endogenous inflammatory mediators such as interferon-gamma (IFNγ), tumor necrosis factor-alpha (TNF-α) and interleukins (IL-1β, IL-6, IL-10 and IL-17) [6,7].…”
Section: Introductionmentioning
confidence: 99%